RT Journal Article
SR Electronic
A1 Kuznar, Wayne
T1 Lesinurad Provides Additional Lowering of SUA in Gout
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 51
SP 10
OP 10
DO 10.1177/155989771451006
UL http://mdc.sagepub.com/content/14/51/10.abstract
AB Current management of gout is suboptimal, and patients often do not achieve serum uric acid (SUA) targets with allopurinol monotherapy. This article discusses the results of 2 replicate phase 3 studies known as Combining Lesinurad With Allopurinol in Inadequate Responders [CLEAR 1 and CLEAR 2; NCT01510158 and NCT01493531, respectively] conducted in symptomatic adults with gout.